Riikka Lund

Title: Riikka Lund - Innovator in Immune-Mediated Disease Research

Introduction

Riikka Lund is a notable inventor based in Raisio, Finland. She has made significant contributions to the field of immunology, particularly in understanding immune-mediated diseases. Her work focuses on identifying compounds that can modulate immune responses, which is crucial for developing new therapeutic strategies.

Latest Patents

Riikka Lund holds a patent for a method of identifying a compound capable of modulating the Th2 polarization of CD4+ lymphocytes. This invention provides methods utilizing novel target genes related to immune-mediated diseases, such as asthma, allergy, and autoimmune diseases. The invention is based on a molecular-level description of the polarization of CD4+ precursor cells (Thp), from which T helper cells are known to originate. Specifically, the present invention offers a method for identifying compounds that can modulate the polarization of CD4+ lymphocytes. Additionally, it relates to a method for assessing the presence of, or disposition to, an immune-related disorder in a subject.

Career Highlights

Riikka Lund is affiliated with Turun Yliopisto, where she continues her research and innovation in the field of immunology. Her work has garnered attention for its potential impact on treating various immune-related disorders. With 1 patent to her name, she is recognized for her contributions to scientific advancements.

Collaborations

Riikka collaborates with Riitta Lahesmaa, a fellow researcher in the field. Their partnership enhances the research efforts aimed at understanding and addressing immune-mediated diseases.

Conclusion

Riikka Lund's innovative work in identifying compounds that modulate immune responses positions her as a key figure in the field of immunology. Her contributions have the potential to lead to significant advancements in the treatment of immune-related disorders.